论文部分内容阅读
乙肝疫苗,乙肝免疫球蛋白联合注射治疗乙肝病毒携带者,治疗组350人,对照组200人。治疗组用乙肝疫苗及乙肝免疫球蛋白联合注射,每周1次,连续8至10周,注射完毕口服中药制剂肝糖,VitB VitC 等3个月一个疗程.然后复查二对半,结果HBsAg 阴转16人,阴转率4.6%,HBeAb 抗体产生30人,使这批病人进入恢复期,减低乙肝病毒的传染性。HCsAg 阴转的病人,于半年、一年后复查,未见复发情况。对照组200人,HBsAg 阴转O 人,HBeAb 抗体产生O 人。经统计学处理,HBsAg 阴转率P<0.05,治疗组高于对
Hepatitis B vaccine, hepatitis B immunoglobulin combined injection of hepatitis B virus carriers, the treatment group of 350 people, the control group of 200 people. The treatment group with hepatitis B vaccine and hepatitis B immunoglobulin injection, once a week for 8 to 10 weeks after the injection of oral administration of traditional Chinese medicine glycosides, VitB VitC and other 3 months a course of treatment and then review two and a half, the results HBsAg negative Turn 16, negative conversion rate of 4.6%, HBeAb antibody produced 30 people, so that these patients into the recovery period, reducing the contagion of hepatitis B virus. HCsAg negative patients, in six months, one year after the review, no recurrence. Control group of 200 people, O HBsAg negative turn, HBeAb antibody O people. After statistical analysis, HBsAg negative conversion rate P <0.05, the treatment group than the right